| Document Date: 2013-08-31 02:43:59
Open Document File Size: 42,34 KBShare Result on Facebook
Company Sponsor Alphapharm Pty Limited / / Event FDA Phase / / Facility Sponsor Alphapharm Pty Limited Chase Building / / IndustryTerm treatment of underlying liver disease / mL solution / opalescent solution / nonfermentable solution / overall management / hydrogen gas / aqueous solution / / MedicalCondition disaccharidase deficiency / Chronic misuse / coma / nausea / hepatic encephalopathy / neuropsychiatric syndrome / chronic portal-systemic encephalopathy / serious constipation / intestinal cramps / chronic constipation / vomiting / hepatic coma / chronic and habitual constipation / Laxative Portal-Systemic Encephalopathy / disorder / renal disease / Administration Portal-Systemic Encephalopathy / Portal-Systemic Encephalopathy / abdominal cramps / constipation / liver disease / dehydration / / MedicalTreatment enema / electrocautery / chemotherapy / antibiotic therapy / / Organization US Federal Reserve / Therapeutic Goods Administration / / Product Lactulose / actilax / / Technology Pharmacokinetics / chemotherapy / / URL www.alphapharm.com.au / /
SocialTag |
Actilax Lactulose PRODUCT INFORMATION Composition